The influence of ramosetron on the analgesic effect of tramadol after thyroidectomy
Not Applicable
Completed
- Conditions
- Endocrine, nutritional and metabolic disease
- Registration Number
- KCT0001007
- Lead Sponsor
- ational Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 128
Inclusion Criteria
128 female patients between 19 and 65 years of age and American Society of Anesthesiologists class physical status I or II who were scheduled for elective thyroid surgery were enrolled.
Exclusion Criteria
We excluded patients with a known allergy to tramadol or ramosetron, alcoholism, epilepsy, nausea or vomiting within 24 h preoperatively, patients receiving antiemetics, antidepressants, anticholinergics, antihistamines, or steroids within 24 h preoperatively, smoking history, prior history of motion sickness or postoperative nausea and vomiting.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method tramadol consumption,
- Secondary Outcome Measures
Name Time Method pain score;incidence of nausea and vomiting